HCID 9947985, compound → HCID 9882561, compound

HRID 2186813Notes

Reaction equation

HRID 2186813 reaction equation
[C:1]([C:5]1[O:9][C:8](/[CH:10]=[CH:11]/[C:12]2[S:16][C:15]([NH:17][C:18](=[O:20])[CH3:19])=[N:14][CH:13]=2)=[N:7][CH:6]=1)([CH3:4])([CH3:3])[CH3:2].[H][H]>C(OCC)(=O)C.[Pd]>[C:1]([C:5]1[O:9][C:8]([CH2:10][CH2:11][C:12]2[S:16][C:15]([NH:17][C:18](=[O:20])[CH3:19])=[N:14][CH:13]=2)=[N:7][CH:6]=1)([CH3:4])([CH3:2])[CH3:3]

Participants

5

Reactant 2

HCID 9947985HCID 9947985, compoundHCID 178418361HCID 178418361, compound

Product 1

HCID 9882561HCID 9882561, compound

Reagents, catalysts & solvents 2

HCID 23938PalladiumCatalystHCID 8857Ethyl AcetateSolvent2×

Procedure

A solution N-[(E)-5-(2-(5-t-butyl-oxazol-2-yl)-vinyl)-thiazol-2-yl]acetamide (67 mg, 0.23 mmol) in ethyl acetate (10 mL) was added to a suspension of pre-reduced Pd/C (10%) in ethyl acetate (5 mL). The reaction flask was fitted with a hydrogen balloon and stirred for 24 hours. The reaction was filtered, and the mixture was resubmitted to hydrogenation using the same conditions as above. After an additional 24 hours, the reaction was filtered through a plug of celite, concentrated, and purified by chromatography (SiO2, 5% MeOH/CHCl3) to give N-[5-(2-(5-t-butyl-oxazol-2-yl)-ethyl)-thiazol-2-yl]-acetamide as a white solid (3.5 mg, 5%, C14H19N3O2S, MS m/e 294 (M+H)+). HPLC-HI 91% at 6.75 min (Zorbax SB C18 column 4.6×75 mm, 10-90% aqueous methanol over 8 minutes containing 0.1% TFA, 2.5 mL/min, monitoring at 220 nm).

Workup

  1. filtrationThe reaction was filtered
  2. waitAfter an additional 24 hours
  3. filtrationthe reaction was filtered through a plug of celite,
  4. concentrationconcentrated
  5. custompurified by chromatography (SiO2, 5% MeOH/CHCl3)

Sources & evidence

ORD record
ord-eb0bf050882749a78ecb1b5e54c0cd58
Source dataset
uspto-grants-2002_06
Patent number
US06407124B1

Reaction notes

Loading…